Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000222391 | SCV000279434 | likely pathogenic | not provided | 2015-09-28 | criteria provided, single submitter | clinical testing | The A734V variant in the GRIN2B gene has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. The A734V variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A734V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. The A734V variant is a strong candidate for a pathogenic variant. However, the possibility it may be a rare benign variant cannot be excluded. |
Institute of Human Genetics, |
RCV001172326 | SCV001335351 | likely pathogenic | Intellectual disability, autosomal dominant 6 | 2017-04-04 | criteria provided, single submitter | clinical testing | This variant was identified as de novo (maternity and paternity confirmed). |